pLV302 Citations (1)
Originally described in: Treatment of a metabolic liver disease by in vivo genome base editing in adult mice.Villiger L, Grisch-Chan HM, Lindsay H, Ringnalda F, Pogliano CB, Allegri G, Fingerhut R, Haberle J, Matos J, Robinson MD, Thony B, Schwank G Nat Med. 2018 Oct;24(10):1519-1525. doi: 10.1038/s41591-018-0209-1. Epub 2018 Oct 8. PubMed Journal
Articles Citing pLV302
| Articles |
|---|
Cytosine base editing systems with minimized off-target effect and molecular size.
Li A, Mitsunobu H, Yoshioka S, Suzuki T, Kondo A, Nishida K.
Nat Commun. 2022 Aug 8;13(1):4531. doi: 10.1038/s41467-022-32157-8.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.